Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05063162 |
|---|---|
| Brief Title: | A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD) (cosMOG) |
| First Submitted : | September 21, 2021 |
| First Submitted that Met QC Criteria : | September 21, 2021 |
| First Posted : | September 30, 2021 |
| Last Update Submitted that Met QC Criteria : | April 25, 2024 |
| Last Update Posted : | April 26, 2024 |